Mortality among patients with HIV infection in the HAART era
Laurence, J.
Aids Reader 14(11): 583-584
2004
ISSN/ISBN: 1053-0894 PMID: 15570669 Document Number: 576092
Document emailed within 1 workday
Related Documents
Chandrasekhar, A.; Gupta, A. 2011: Nutrition and disease progression pre-highly active antiretroviral therapy (HAART) and post-HAART: can good nutrition delay time to HAART and affect response to HAART? American Journal of Clinical Nutrition 94(6): 1703s-1715sGrinsztejn, B.; Veloso, V.G.; Friedman, R.K.; Moreira, R.I.; Luz, P.M.; Campos, D.P.; Pilotto, J.é H.; Cardoso, S.W.; Keruly, J.C.; Moore, R.D. 2009: Early mortality and cause of deaths in patients using HAART in Brazil and the United States Aids 23(16): 2107-2114
DeSilva, M.B.; Merry, S.P.; Fischer, P.R.; Rohrer, J.E.; Isichei, C.O.; Cha, S.S. 2009: Youth, unemployment, and male gender predict mortality in AIDS patients started on HAART in Nigeria Aids Care 21(1): 70-77
Wen, Y.; Shi, Y.; Jiang, C.; Detels, R.; Wu, D. 2013: HIV/AIDS patients' medical and psychosocial needs in the era of HAART: a cross-sectional study among HIV/AIDS patients receiving HAART in Yunnan, China Aids Care 25(7): 915-925
Jáuregui Camargo, L.; Ruiz-Palacios, G.; Guerrero Almeida, L.; Niño Oberto, S.; Peasey, A.; Sierra Madero, J. 2003: Evaluation of highly active antiretroviral therapy (HAART) in a cohort of patients with HIV infection in Mexico Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 55(1): 10-17
Djarma, O.ïm.; Nguyen, Y.; Renois, F.; Djimassal, A.; Banisadr, F.; Andreoletti, L. 2014: Continuous free access to HAART could be one of the potential factors impacting on loss to follow-up in HAART-eligible patients living in a resource-limited setting: N'djamena, Chad Transactions of the Royal Society of Tropical Medicine and Hygiene 108(11): 735-738
Da Silva, C.A.L.; Dourado, I.ês.; Dahia, S.R.; Harzheim, E.; Rutherford, G.W. 2008: Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil Journal of Public Health Dentistry 68(3): 178-181
Grinsztejn, B.; Luz, P.M.; Pacheco, A.G.; Santos, D.V.G.; Velasque, L.; Moreira, R.I.; Guimarães, M.Regina.C.; Nunes, Eão.P.; Lemos, A.S.; Ribeiro, S.R.; Campos, D.P.; Vitoria, M.A.A.; Veloso, V.G. 2013: Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era Plos one 8(4): E59768
Gadelha, A.; Accácio, N.áu.; Grinzstejn, B.; Veloso, V.éa.; da Silveira, L.B.; Fandinho, F.át.; Saad, M.H.; Lourenço, M.C.; Rolla, V. 2002: Low incidence of colonization and no cases of disseminated Mycobacterium avium complex infection (DMAC) in Brazilian AIDS patients in the HAART era Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 6(5): 252-257
Akinbo, F.O.; Omoregie, R. 2012: Plasmodium falciparum infection in HIV-infected patients on highly active antiretroviral therapy (HAART) in Benin City, Nigeria Journal of Research in Health Sciences 12(1): 15-18
De Beaudrap, P.; Etard, J-François.; Ecochard, Ré.; Diouf, A.; Dieng, Aé.Baba.; Cilote, V.; Ndiaye, I.; Guèye, Nèye.Fatou.Ngom.; Guèye, P.Mandoumbé.; Sow, P.Salif.; Mboup, S.; Ndoye, I.; Delaporte, E. 2008: Change over time of mortality predictors after HAART initiation in a Senegalese cohort European Journal of Epidemiology 23(3): 227-234
Smith, D.E.; Chan, D.J. 2004: Treating primary HIV infection--is your HAART in it? Sexual Health 1(3): 131-135
Lauenroth-Mai, E. 2002: Therapy in HIV infection: HAART: possibilities and limits Pflege Zeitschrift 55(12): 857-860
Miiro, G.; Todd, J.; Mpendo, J.; Watera, C.; Munderi, P.; Nakubulwa, S.; Kaddu, I.; Rutebarika, D.; Grosskurth, H. 2009: Reduced morbidity and mortality in the first year after initiating highly active anti-retroviral therapy (HAART) among Ugandan adults Tropical Medicine and International Health: Tm and Ih 14(5): 556-563
Stoll, M.; Claes, C.; Schulte, E.; Graf von der Schulenburg, J.M.; Schmidt, R.E. 2002: Direct costs for the treatment of HIV-infection in a German cohort after the introduction of HAART European Journal of Medical Research 7(11): 463-471
Tseng, S.-H.; Jiang, D.D.-S.; Hoi, H.-S.; Yang, S.-L.; Hwang, K.-P. 2009: Impact of HAART therapy on co-infection of tuberculosis and HIV cases for 9 years in Taiwan American Journal of Tropical Medicine and Hygiene 80(4): 675-677
Shah, I.; Katira, B. 2009: Tuberculosis co-infection in HAART naive HIV infected children - an Indian study Indian Journal of Pediatrics 76(9): 966-967
Giralt, M.; Domingo, P.; Guallar, J.P.; Rodriguez de la Concepción, M.Luísa.; Alegre, M.; Domingo, J.C.; Villarroya, F. 2006: HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy Antiviral Therapy 11(6): 729-740
Lu, X.-m.; Guo, F.-m.; Yang, Y.; Qiu, H.-b. 2011: Effects of statins on mortality in patients with infection: a systematic review Zhonghua Yi Xue Za Zhi 91(27): 1875-1878
Fonseca, M.Goretti.P.; Lucena, F.de.Fátima.A.; Sousa, A.de.; Bastos, F.I. 2007: AIDS mortality, "race or color", and social inequality in a context of universal access to highly active antiretroviral therapy (HAART) in Brazil, 1999-2004 Cadernos de Saude Publica 23 Suppl. 3: S445-S455